Heptenal (HepcinatLP) - a combination drug

Heptenal (HepcinatLP) is a combination drug with an established dose tablets containing ledipasvir is an inhibitor (blocker) of NS5A of hepatitis C and sofosbuvir, a nucleotide analogue, a polymerase inhibitor NS5Bвируса hepatitis C.

Each tablet contains 90mg ladieswear and 400 mg of sofosbuvir.

Auxiliary substances: colloidal silicon dioxide, copovidone, croscarmellose sodium, lactose monohydrate, magnesium stearate, and microscopic particles of cellulose. Pills are produced in solid form coated, contain the following inactive ingredients: ferric oxide (yellow), polyethylene glycol, polyvinyl alcohol, talc, titanium dioxide.